Results

Rafael Holdings Inc.

10/28/2021 | Press release | Distributed by Public on 10/28/2021 05:44

Rafael Holdings Provides Update on Rafael Pharmaceuticals’ Two Phase 3 Trials of CPI-613® (Devimistat), AVENGER 500 in Metastatic Pancreatic Cancer and ARMADA 2000 in Relapsed[...]